Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Literature
1.
Ece A, Kelekçi S, Kocamaz H et al (2008) Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura. Clin Rheumatol 27:163–169PubMedCrossRef
2.
Michel TM, Camara S, Tatschner T et al (2008) Increased xanthine oxidase in the thalamus and putamen in depression. World J Biol Psychiatry 12:1–7CrossRef
3.
Puddu P, Puddu GM, Cravero E et al (2008) The molecular sources of reactive oxygen species in hypertension. Blood Press 17:70–77PubMedCrossRef
4.
Murat T, Ilker D, Sukran E et al (2007) Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactive systemic lupus erythematosus. APLAR J Rheumatol 10:101–106CrossRef
5.
Butler R, Morris AD, Belch JJ et al (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746–751PubMed
Metadata
Title
Elevated serum xanthine oxidase activities in patients with Henoch–Schonlein purpura
Authors
Tao Chen
Zai-Pei Guo
Yu-hong Zhang
Ying Gao
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 11/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1253-5

Other articles of this Issue 11/2009

Clinical Rheumatology 11/2009 Go to the issue

Original Article

Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus

Original Article

Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population

Case Report

Hereditary gelsolin amyloidosis mimicking Sjögren’s syndrome

Case Report

Acute bilateral phrenic neuropathy following treatment with adalimumab

Case Report

Psoriatic arthritis and chronic lymphoedema: treatment efficacy by adalimumab

Review Article

The use of extracorporeal shock waves in the treatment of osteonecrosis of the femoral head: a systematic review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits